Search Results - "Metan, G."

Is Aspergillus lateral device ready to implement to the daily practice? The question rising from the new European Invasive Aspergillosis management guideline by Metan, G.

Get full text

The interaction between piperacillin–tazobactam and Aspergillus galactomannan antigenemia assay: is the story over? by Metan, G.

Get full text

The influence of the control group characteristics for the diagnostic performance of 1,3-beta-D-glucan in invasive aspergillosis by Metan, G., Elmali, F.

Get full text

interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infections by Metan, G, Ağkuş, Ç, Buldu, H, Koç, A. N

“…Background The aim of this study was to investigate the interaction between intravenous piperacillin/tazobactam treatment and Aspergillus galactomannan antigen…”
Get full text

Outbreak of postoperative empyema caused by Serratia marcescens in a thoracic surgery unit by Ulu-Kilic, A, Parkan, O, Ersoy, S, Koc, D, Percin, D, Onal, O, Metan, G, Alp, E

“…Summary An increase in the number of cases of postoperative empyema due to S. marcescens was recognized in the intensive care unit (ICU) of our Division of…”
Get full text

Diagnosis of Aspergillus niger peritonitis in a peritoneal dialysis patient by peritoneal galactomannan and β-D-glucan detection by Ates, O, Metan, G, Dundar, T, Kiziltepe, M, Kocyigit, I, Unal, A, Sipahioglu, M, Oymak, O, Tokgoz, B

Get full text

Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1 by Ingram, R. J., Harris, A., Ascough, S., Metan, G., Doganay, M., Ballie, L., Williamson, E. D., Dyson, H., Robinson, J. H., Sriskandan, S., Altmann, D. M.

“…Summary Anthrax is a toxin‐mediated disease, the lethal effects of which are initiated by the binding of protective antigen (PA) with one of three reported…”
Get full text

Clinical Experience with Tigecycline in the Treatment of Carbapenem-Resistant Acinetobacter Infections by Metan, G., Alp, E., Yildiz, O., Percin, D., Aygen, B., Sumerkan, B.

“…Tigecycline is a promising therapeutic option against many current multidrug resistant pathogens. The aim of this retrospective study was to determine the…”
Get full text

Rapid detection of antibacterial resistance in emerging Gram-positive cocci by Metan, G., Zarakolu, P., Unal, S.

“…Effective infection control efforts obviously depend on the performance of the laboratory to detect emerging resistant pathogens accurately and confirm…”
Get full text

Naturally occurring cutaneous anthrax: antibiotic treatment and outcome by Kayabas, U, Karahocagil, M K, Ozkurt, Z, Metan, G, Parlak, E, Bayindir, Y, Kalkan, A, Akdeniz, H, Parlak, M, Simpson, A J H, Doganay, M

“…Cutaneous anthrax (CA) is the most common clinical presentation in human anthrax, but the duration of antibiotic therapy in naturally occurring CA is…”
Get more information

P1365 Dissemination of a VIM-positive Pseudomonas aeruginosa clone in a university hospital, Ankara, Turkey by Gurkan Aydin, N, Metan, G, Altun, B, Zarakolu, P

Get full text

A forgotten diagnosis in emergency department: tetanus by Akdur, O, Ozkan, S, Durukan, P, Koyuncu, M, Ikizceli, I, Metan, G

“…Tetanus is a serious and acute life-threatening disease caused by toxins of "Clostridium tetani". Although it is generally a disease of developing countries,…”
Get more information

Predictors of Mortality in Patients with Bacteremia of Unknown Source Due to Extended Spectrum Beta-Lactamase Producing Escherichia coli by Metan, G., Altinbas, A., Zarakolu, P., Yildiz, O., Cetinkaya Sardan, Y., Sumerkan, B., Hascelik, G.

Get full text

Corrigendum to ‘‘Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey’’ [Inf. Gen. Evol. 14 (2013) 92–97] by Metan, G.

Get full text

A multidisciplinary team approach to the management of patients with suspected or diagnosed invasive fungal disease by Ben-Ami, Ronen, Halaburda, Kazimierz, Klyasova, Galina, Metan, Gökhan, Torosian, Tigran, Akova, Murat

“…Implementation of evidence-based guidelines for the treatment of invasive fungal disease (IFD) requires collaboration among numerous clinical and laboratory…”
Get full text

Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia by Metan, Gokhan, Uzun, Omrum

Get full text

A change for the antibacterial treatment policy to decrease carbapenem consumption at a hematopoieteic stem cell transplant center by Metan, G, Kaynar, L, Yozgat, N, Elmali, F, Kurkcuoglu, C Altay, Alp, E, Cetin, M

Get full text

The effectiveness of hepa filtered rooms plus fluconazol prophylaxis for preventation of invasive fungal diseases in allogenic stem cell transplant patients by Kurkcuoglu, C Altay, Metan, G, Kaynar, L, Elmali, F, Alp, E, Cetin, M

Get full text

Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli by Metan, Gokhan, Zarakolu, Pınar, Çakır, Banu, Hascelik, Gulsen, Uzun, Omrum

“…This study was conducted to assess the clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. A total…”
Get full text

Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum β-lactamase-producing by METAN, G, ZARAKOLU, P, CAKIR, B, HASCELIK, G, UZUN, O

Get full text